» Articles » PMID: 24549231

Anticancer and Multidrug Resistance-reversal Effects of Solanidine Analogs Synthetized from Pregnadienolone Acetate

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2014 Feb 20
PMID 24549231
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A set of solanidine analogs with antiproliferative properties were recently synthetized from pregnadienolone acetate, which occurs in Nature. The aim of the present study was an in vitro characterization of their antiproliferative action and an investigation of their multidrug resistance-reversal activity on cancer cells. Six of the compounds elicited the accumulation of a hypodiploid population of HeLa cells, indicating their apoptosis-inducing character, and another one caused cell cycle arrest at the G2/M phase. The most effective agents inhibited the activity of topoisomerase I, as evidenced by plasmid supercoil relaxation assays. One of the most potent analogs down-regulated the expression of cell-cycle related genes at the mRNA level, including tumor necrosis factor alpha and S-phase kinase-associated protein 2, and induced growth arrest and DNA damage protein 45 alpha. Some of the investigated compounds inhibited the ABCB1 transporter and caused rhodamine-123 accumulation in murine lymphoma cells transfected by human MDR1 gene, expressing the efflux pump (L5178). One of the most active agents in this aspect potentiated the antiproliferative action of doxorubicin without substantial intrinsic cytostatic capacity. The current results indicate that the modified solanidine skeleton is a suitable substrate for the rational design and synthesis of further innovative drug candidates with anticancer activities.

Citing Articles

Glycoalkaloids of Plants in the Family Solanaceae (Nightshade) as Potential Drugs.

Ostreikova T, Kalinkina O, Bogomolov N, Chernykh I Pharm Chem J. 2022; 56(7):948-957.

PMID: 36277854 PMC: 9579588. DOI: 10.1007/s11094-022-02731-x.


Antioxidants in Potatoes: A Functional View on One of the Major Food Crops Worldwide.

Hellmann H, Goyer A, Navarre D Molecules. 2021; 26(9).

PMID: 33922183 PMC: 8122721. DOI: 10.3390/molecules26092446.


Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling.

Latif A, Jernei T, Podolski-Renic A, Kuo C, Vagvolgyi M, Girst G Antioxidants (Basel). 2020; 9(6).

PMID: 32545536 PMC: 7346169. DOI: 10.3390/antiox9060519.


Synthesis and Cytotoxic Activity of New Vindoline Derivatives Coupled to Natural and Synthetic Pharmacophores.

Keglevich A, Danyi L, Rieder A, Horvath D, Szigetvari A, Dekany M Molecules. 2020; 25(4).

PMID: 32102414 PMC: 7070384. DOI: 10.3390/molecules25041010.


Endophytic Fungi of Native Plants Reveal High Taxonomic Diversity and Unique Profiles of Secondary Metabolites.

Teimoori-Boghsani Y, Ganjeali A, Cernava T, Muller H, Asili J, Berg G Front Microbiol. 2020; 10:3013.

PMID: 32010087 PMC: 6978743. DOI: 10.3389/fmicb.2019.03013.


References
1.
Punjabi S, Cook L, Kersey P, Marks R, Cerio R . Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study. Int J Dermatol. 2008; 47(1):78-82. DOI: 10.1111/j.1365-4632.2007.03363.x. View

2.
Gupta A, Kumar B, Negi A . Current status on development of steroids as anticancer agents. J Steroid Biochem Mol Biol. 2013; 137:242-70. DOI: 10.1016/j.jsbmb.2013.05.011. View

3.
Pennington J, Muldoon Jacobs K, Sun L, Bar-Sela G, Mishra M, Gius D . Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Curr Pharm Des. 2007; 13(33):3368-77. View

4.
Chellappan S, Giordano A, Fisher P . Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol. 1998; 227:57-103. DOI: 10.1007/978-3-642-71941-7_4. View

5.
Park M, Lee S . Cell cycle and cancer. J Biochem Mol Biol. 2003; 36(1):60-5. DOI: 10.5483/bmbrep.2003.36.1.060. View